Teva Pharmaceuticals
TEVA
TEVA
507 hedge funds and large institutions have $11.2B invested in Teva Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 129 increasing their positions, 209 reducing their positions, and 123 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 98 | Existing positions closed: 123
23% less call options, than puts
Call options by funds: $617M | Put options by funds: $807M
38% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 209
Holders
507
Holding in Top 10
13
Calls
$617M
Puts
$807M
Top Buyers
| 1 | +$543M | |
| 2 | +$358M | |
| 3 | +$235M | |
| 4 |
BC
Brahman Capital
New York
|
+$188M |
| 5 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$174M |
Top Sellers
| 1 | -$243M | |
| 2 | -$188M | |
| 3 | -$103M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$95.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$95.9M |